These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 17537308)

  • 21. Phosphatidylinositol 3-kinase inhibition by LY294002 radiosensitizes human cervical cancer cell lines.
    Lee CM; Fuhrman CB; Planelles V; Peltier MR; Gaffney DK; Soisson AP; Dodson MK; Tolley HD; Green CL; Zempolich KA
    Clin Cancer Res; 2006 Jan; 12(1):250-6. PubMed ID: 16397049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phosphatidylinositol 3-kinase mediates angiogenesis and vascular permeability associated with ovarian carcinoma.
    Hu L; Hofmann J; Jaffe RB
    Clin Cancer Res; 2005 Nov; 11(22):8208-12. PubMed ID: 16299254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aberration of the PI3K/AKT/mTOR signaling in epithelial ovarian cancer and its implication in cisplatin-based chemotherapy.
    Zhang HY; Zhang PN; Sun H
    Eur J Obstet Gynecol Reprod Biol; 2009 Sep; 146(1):81-6. PubMed ID: 19540648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
    Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of EGFR/PI3K/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells.
    Zhou C; Qiu L; Sun Y; Healey S; Wanebo H; Kouttab N; Di W; Yan B; Wan Y
    Int J Oncol; 2006 Jul; 29(1):269-78. PubMed ID: 16773209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect and mechanism of endoplasmic reticulum stress on cisplatin resistance in ovarian carcinoma].
    Tian J; Hu X; Qu Q
    Zhonghua Zhong Liu Za Zhi; 2014 May; 36(5):324-8. PubMed ID: 25030585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect and mechanism of LY294002 on growth of fibrosarcoma cell line HT1080].
    Zhou H; Huang XY; Yang T; Wang T; Xu D; Wen FQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jan; 41(1):20-3. PubMed ID: 20369463
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Down-regulation of PIK3CG, a catalytic subunit of phosphatidylinositol 3-OH kinase, by CpG hypermethylation in human colorectal carcinoma.
    Semba S; Itoh N; Ito M; Youssef EM; Harada M; Moriya T; Kimura W; Yamakawa M
    Clin Cancer Res; 2002 Dec; 8(12):3824-31. PubMed ID: 12473596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated phosphatidylinositol 3-kinase activation and its clinicopathological significance in cervical cancer.
    Zhang XY; Zhang HY; Zhang PN; Lu X; Sun H
    Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):237-44. PubMed ID: 18395956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Activation of phosphatidylinositol 3-kinase-protein kinase B (PI3K-PKB) induced by 17beta-estradiol in endometrial carcinoma cell (Ishikawa)].
    Guo RX; Wei LH; Wang JL; Sun PM; Sun XL
    Zhonghua Fu Chan Ke Za Zhi; 2004 Jul; 39(7):469-73. PubMed ID: 15347471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathway overcomes cisplatin resistance in ovarian carcinoma cells.
    Nonaka M; Itamochi H; Kawaguchi W; Kudoh A; Sato S; Uegaki K; Naniwa J; Sato S; Shimada M; Oishi T; Terakawa N; Kigawa J; Harada T
    Int J Gynecol Cancer; 2012 Jul; 22(6):922-9. PubMed ID: 22672985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macrophage migration inhibitory factor regulates proliferation of gastric cancer cells via the PI3K/Akt pathway.
    Li GQ; Xie J; Lei XY; Zhang L
    World J Gastroenterol; 2009 Nov; 15(44):5541-8. PubMed ID: 19938192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Reversal of drug resistance in human ovarian cancer cells by wild-type PTEN gene and its mechanisms].
    Wu HJ; Wu HT; Weng DH; Xing H; Lu YP; Ma D
    Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):612-6. PubMed ID: 17983517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The lysophosphatidic acid (LPA) receptors their expression and significance in epithelial ovarian neoplasms.
    Wang P; Wu X; Chen W; Liu J; Wang X
    Gynecol Oncol; 2007 Mar; 104(3):714-20. PubMed ID: 17204312
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of norcantharidin's derivative Nd3 on proliferation of human ovarian cancer cell line SKOV3 and its possible mechanisms].
    Cao JH; Xu B; Li M; Wu DZ; Huang W; Cui JR
    Ai Zheng; 2007 Apr; 26(4):361-6. PubMed ID: 17430652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synergistic augmentation of antimicrotubule agent-induced cytotoxicity by a phosphoinositide 3-kinase inhibitor in human malignant glioma cells.
    Shingu T; Yamada K; Hara N; Moritake K; Osago H; Terashima M; Uemura T; Yamasaki T; Tsuchiya M
    Cancer Res; 2003 Jul; 63(14):4044-7. PubMed ID: 12874004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Relation of ME491/CD63 gene and integrin alpha5 in the invasion and metastases of ovarian cancer].
    Xia ZJ; Zhang SL; Zhou Z
    Zhonghua Fu Chan Ke Za Zhi; 2005 Nov; 40(11):765-9. PubMed ID: 16324252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin-like growth factor-I receptor in proliferation and motility of pancreatic cancer.
    Tomizawa M; Shinozaki F; Sugiyama T; Yamamoto S; Sueishi M; Yoshida T
    World J Gastroenterol; 2010 Apr; 16(15):1854-8. PubMed ID: 20397262
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of PI3K/AKT inhibitor on benign prostate hyperplasia and its mechanism: an experimental study].
    Jin P; Wang YH; Peng YG; Hu S; Lu Q; Yang LY
    Zhonghua Nan Ke Xue; 2010 Dec; 16(12):1068-75. PubMed ID: 21348195
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Growth inhibition of combined pathway inhibitors on KRAS mutated non-small cell lung cancer cell line].
    Li ZW; Yang ZL; Feng HL; Bian XC; Liu YY; Liu YQ
    Zhonghua Bing Li Xue Za Zhi; 2013 May; 42(5):330-5. PubMed ID: 24004591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.